Over the last 20 years, three new technologies have come together to reshape the way information enters our lives. First, of course, there was the Web, starting around 1993. Then came social networking, starting around 2003. And finally—hugely amplifying the effects... Read more »
It’s beginning to look a lot like Christmas, especially at San Diego’s Rempex Pharmaceuticals, which was acquired in one of the bigger deals of the year. We have details, along with the rest of the region’s recent life sciences news.
—The... Read more »
In a move to democratize its data visualization technology and expand its market, Solana Beach, CA-based Roambi says today it is launching a new iPad app intended to bring the power of its Roambi Flow publishing platform to the Internet... Read more »
Just in time for this summer’s 2014 FIFA World Cup soccer tournament in Brazil, San Diego-based Onde Ficar says it has raised $2 million in a Series A funding round to build out its Web-based applications for marketing and managing small... Read more »
HouseCall, a San Diego-based startup that enables homeowners to tap an online marketplace for plumbers, housekeepers, and other home maintenance services, says it has raised $1.5 million in seed funding from San Francisco’s e.ventures, an initial investor in Angie’s List and... Read more »
Cubist Pharmaceuticals (NASDAQ: CBST) just got some more promising results to take to regulators next year.
The Lexington, MA-based company said today that CXA-201— the antibiotic it acquired when it bought out Calixa Therapeutics a few years ago—succeeded in the... Read more »
There are no flyover zones in the United States. That’s the way Xconomy views the map, anyway, because we see innovation happening all over America.
So it is with great pleasure that today we are launching Xconomy Wisconsin, the ninth... Read more »
Every year, Science magazine profiles its “Breakthrough of the Year.” People get excited. But what many readers don’t fully appreciate is that these discoveries—at least in biomedicine—are almost always decades away from turning into useful new drugs, diagnostics, or... Read more »
[Updated, Dec. 14, 2013--see below] Charles Vest, one of the leading contemporary figures of higher education, engineering, and science, and an early friend of Xconomy, has passed away. He was 72, and the cause was cancer, according to an announcement from... Read more »
Drug development and deals continued apace as the Christmas holiday draws near. Here’s the latest in San Diego’s life sciences news.
—-Orexigen Therapeutics (NASDAQ: OREX) said it has resubmitted its application with the FDA for its new weight-loss drug,... Read more »